Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 177 | 0.91 |
| pathways Reactome | 1 pathway; mostly energy | 0.60 |
No case: the score is under the bar. Receipt 16435
Sealed predictions
- SLC19A3 in dopamine neurons, braak+0.63 (p 0.069) → +0.00 (p 1.000)receipt 16442
Swarm cases
receipt 16442: SLC19A3 in dopamine neurons, braak
- power
- full sample +0.37 (p 0.135, n 18), 95% CI -0.12 to +0.71. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.32 (p 0.194, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.30 (p 0.228, n 18). could be the mix.
- skeptic
- leave-one-out range +0.27 to +0.51, sign flips 0; without severely affected donors +0.37 (p 0.135, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC19A3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts